BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 24993989)

  • 1. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
    J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
    Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
    JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S; Ormiston J; Bergmann MW; Sievert H; Schwindt A; Werner N; Vogel B; Colombo A
    EuroIntervention; 2015 Feb; 10(10):1221-9. PubMed ID: 25452198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and short-term efficacy of renal sympathetic denervation in the treatment of resistant hypertension].
    Jiang XJ; Liang T; Dong H; Peng M; Ma WJ; Guan T; Zhang HM; Bian J; Xu B; Gao RL
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3265-8. PubMed ID: 23328511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First report of transradial renal denervation with the dedicated radiofrequency Iberis™ catheter.
    Honton B; Pathak A; Sauguet A; Fajadet J
    EuroIntervention; 2014; 9(12):1385-8. PubMed ID: 24161437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
    Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-man radial access renal denervation with the ReCor Radiance™ catheter.
    Daemen J; Van Mieghem N
    EuroIntervention; 2015 Feb; 10(10):1209-12. PubMed ID: 25493912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
    Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP; Papademetriou V; Dimitriadis KS; Kasiakogias A; Tsiachris D; Worthley MI; Sinhal AR; Chew DP; Meredith IT; Malaiapan Y; Thomopoulos C; Kallikazaros I; Tousoulis D; Worthley SG
    Int J Cardiol; 2015 Dec; 201():345-50. PubMed ID: 26301677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H; Schofer J; Ormiston J; Hoppe UC; Meredith IT; Walters DL; Azizi M; Diaz-Cartelle J; Cohen-Mazor M
    EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 Investigators
    Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.